According to the Washington Post, 13 states currently cover the drugs for Medicaid patients, while Medicare prohibits ...

The Trump administration is planning an experiment to cover weight loss drugs under Medicare and Medicaid, potentially ...

Drugs known as GLP-1 receptor agonists were initially developed to treat Type 2 diabetes but have become a cultural ...

Minnesota Gov. Tim Walz declared Wednesday "Medicaid and Medicare Day," and marked the day by discussing the anticipated ...

The Trump administration is planning an experiment to cover weight-loss drugs under Medicare and Medicaid, the Washington ...

An estimated 4.4% of primary care physicians left Medicare in 2023 — a higher exit rate than specialists — according to a new ...

In 1965, President Lyndon B. Johnson signed Medicare into law, dedicating it to former President Harry Truman, who "planted ...

A five-year experiment aims to open access to blockbuster GLP‑1 drugs for obesity, something advocates have pushed for years.

Thousands of Rhode Island seniors and disabled residents no longer covered for non-emergency visits at four local hospitals ...

Medicare and Medicaid could expand coverage of GLP-1 drugs, such as Ozempic and Wegovy, and pay for patients’ use of the ...

The federal government's Medicare program and older adults together spend $4.4 billion a year on care that has low clinical ...

The federal government is expected to start a 5-year-long experiment that will provide some limited coverage of obesity ...